India · Delayed Price · Currency is INR Oncternal Therapeutics Statistics
Total Valuation
BOM:543653 has a market cap or net worth of INR 181.12 billion. The enterprise value is 181.85 billion.
| Market Cap | 181.12B |
| Enterprise Value | 181.85B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | 250.59M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 65.30M |
Valuation Ratios
The trailing PE ratio is 89.45 and the forward PE ratio is 58.79.
| PE Ratio | 89.45 |
| Forward PE | 58.79 |
| PS Ratio | 6.70 |
| PB Ratio | 12.23 |
| P/TBV Ratio | 14.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 89.81 |
| EV / Sales | 6.73 |
| EV / EBITDA | 54.16 |
| EV / EBIT | 73.83 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | n/a |
| Interest Coverage | 14.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.95% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 10.56M |
| Profits Per Employee | 791,242 |
| Employee Count | 2,559 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543653 has paid 698.49 million in taxes.
| Income Tax | 698.49M |
| Effective Tax Rate | 26.36% |
Stock Price Statistics
The stock price has decreased by -7.95% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.95% |
| 50-Day Moving Average | 743.61 |
| 200-Day Moving Average | 732.52 |
| Relative Strength Index (RSI) | 40.42 |
| Average Volume (20 Days) | 138,844 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543653 had revenue of INR 27.03 billion and earned 2.02 billion in profits. Earnings per share was 8.08.
| Revenue | 27.03B |
| Gross Profit | 8.82B |
| Operating Income | 2.46B |
| Pretax Income | 2.65B |
| Net Income | 2.02B |
| EBITDA | 3.36B |
| EBIT | 2.46B |
| Earnings Per Share (EPS) | 8.08 |
Balance Sheet
The company has 2.55 billion in cash and 2.31 billion in debt, giving a net cash position of 241.02 million.
| Cash & Cash Equivalents | 2.55B |
| Total Debt | 2.31B |
| Net Cash | 241.02M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 14.81B |
| Book Value Per Share | 55.25 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 32.62%, with operating and profit margins of 9.11% and 7.49%.
| Gross Margin | 32.62% |
| Operating Margin | 9.11% |
| Pretax Margin | 9.80% |
| Profit Margin | 7.49% |
| EBITDA Margin | 12.42% |
| EBIT Margin | 9.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.14%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 1.12% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |